1. Home
  2. FBK vs TARS Comparison

FBK vs TARS Comparison

Compare FBK & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FB Financial Corporation

FBK

FB Financial Corporation

HOLD

Current Price

$52.70

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$64.38

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBK
TARS
Founded
1906
2016
Country
United States
United States
Employees
N/A
370
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.7B
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
FBK
TARS
Price
$52.70
$64.38
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$64.50
$89.00
AVG Volume (30 Days)
191.5K
649.2K
Earning Date
04-13-2026
05-06-2026
Dividend Yield
1.56%
N/A
EPS Growth
N/A
48.21
EPS
1.10
N/A
Revenue
N/A
$451,360,000.00
Revenue This Year
$41.72
$56.43
Revenue Next Year
$7.21
$30.19
P/E Ratio
$46.94
N/A
Revenue Growth
N/A
146.71
52 Week Low
$42.29
$38.51
52 Week High
$62.37
$85.25

Technical Indicators

Market Signals
Indicator
FBK
TARS
Relative Strength Index (RSI) 47.28 50.82
Support Level $52.27 $60.38
Resistance Level $53.04 $67.24
Average True Range (ATR) 1.10 3.70
MACD -0.15 0.30
Stochastic Oscillator 43.10 74.62

Price Performance

Historical Comparison
FBK
TARS

About FBK FB Financial Corporation

FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates majority of revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: